Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,107 | 511 | 94.5% |
| Entertainment | $257.99 | 6 | 2.2% |
| Education | $198.00 | 2 | 1.7% |
| Travel and Lodging | $190.97 | 1 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $4,509 | 249 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,231 | 73 | $0 (2024) |
| Celgene Corporation | $770.65 | 27 | $0 (2024) |
| Romark Laboratories, LC | $664.95 | 18 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $594.32 | 5 | $0 (2023) |
| Boston Scientific Corporation | $545.38 | 6 | $0 (2023) |
| Janssen Biotech, Inc. | $522.68 | 24 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $472.83 | 4 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $454.11 | 20 | $0 (2024) |
| Wilson Cook Medical Incorporated | $248.14 | 5 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,686 | 80 | ABBVIE INC. ($600.73) |
| 2023 | $2,013 | 96 | ABBVIE INC. ($907.70) |
| 2022 | $2,641 | 113 | ABBVIE INC. ($1,248) |
| 2021 | $1,142 | 69 | Takeda Pharmaceuticals U.S.A., Inc. ($295.07) |
| 2020 | $561.88 | 36 | AbbVie Inc. ($285.48) |
| 2019 | $1,074 | 37 | AbbVie, Inc. ($408.07) |
| 2018 | $1,254 | 49 | Romark Laboratories, LC ($354.36) |
| 2017 | $1,383 | 40 | AbbVie, Inc. ($417.53) |
All Payment Transactions
520 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $5.63 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/10/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: VIROLOGY | ||||||
| 12/10/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $2.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Gastroenterology | ||||||
| 11/27/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $10.22 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/23/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.47 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $1.57 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.72 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $33.15 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/01/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $22.08 | General |
| Category: Neuroscience | ||||||
| 09/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Immunology | ||||||
| 09/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/13/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $35.14 | General |
| Category: Neuroscience | ||||||
| 09/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $11.64 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/09/2024 | Janssen Scientific Affairs, LLC | — | Food and Beverage | In-kind items and services | $132.12 | General |
| 09/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $2.89 | General |
| Category: IMMUNOLOGY | ||||||
| 09/05/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $22.73 | General |
| Category: Neuroscience | ||||||
| 09/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $0.30 | General |
| Category: IMMUNOLOGY | ||||||
| 09/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: IMMUNOLOGY | ||||||
| 09/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $0.75 | General |
| Category: IMMUNOLOGY | ||||||
| 08/22/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $11.13 | General |
| Category: Immunology | ||||||
| 08/20/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $23.06 | General |
| Category: THERAPY FOR CSID | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 309 | 352 | $304,237 | $40,821 |
| 2022 | 9 | 332 | 364 | $158,080 | $39,389 |
| 2021 | 11 | 399 | 435 | $175,431 | $44,585 |
| 2020 | 15 | 540 | 565 | $244,368 | $51,860 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 84 | 85 | $114,697 | $17,274 | 15.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 68 | 102 | $33,798 | $8,928 | 26.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 50 | 55 | $62,871 | $4,032 | 6.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 17 | 17 | $18,294 | $2,988 | 16.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $12,222 | $2,908 | 23.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 20 | 20 | $27,690 | $1,549 | 5.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 22 | $4,990 | $1,321 | 26.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $16,500 | $1,297 | 7.9% |
| 43450 | Dilation of esophagus | Facility | 2023 | 15 | 16 | $13,175 | $523.01 | 4.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 60 | 60 | $55,500 | $12,189 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 62 | 84 | $14,925 | $7,744 | 51.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 26 | 26 | $17,680 | $4,548 | 25.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 50 | 54 | $28,350 | $4,446 | 15.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 32 | 32 | $8,780 | $3,959 | 45.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 40 | 45 | $5,545 | $2,873 | 51.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 21 | 21 | $15,330 | $1,867 | 12.2% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 15 | 15 | $6,975 | $976.22 | 14.0% |
| 43450 | Dilation of esophagus | Facility | 2022 | 26 | 27 | $4,995 | $785.23 | 15.7% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Office | 2021 | 47 | 47 | $42,300 | $9,642 | 22.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 50 | 71 | $13,565 | $6,762 | 49.8% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 30 | 30 | $27,525 | $6,155 | 22.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 37 | 47 | $7,835 | $4,165 | 53.2% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 39 | 41 | $23,045 | $3,024 | 13.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Office | 2021 | 16 | 16 | $9,600 | $2,904 | 30.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 22 | 22 | $6,502 | $2,805 | 43.1% |
About Dr. Nav Grandhi, M.D
Dr. Nav Grandhi, M.D is a Gastroenterology healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1497754469.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nav Grandhi, M.D has received a total of $11,754 in payments from pharmaceutical and medical device companies, with $1,686 received in 2024. These payments were reported across 520 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($11,107).
As a Medicare-enrolled provider, Grandhi has provided services to 1,580 Medicare beneficiaries, totaling 1,716 services with total Medicare billing of $176,654. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Cincinnati, OH
- Active Since 07/20/2005
- Last Updated 02/26/2014
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1497754469
Products in Payments
- RINVOQ (Biological) $1,551
- ZEPOSIA (Drug) $1,365
- Humira (Biological) $800.99
- Alinia Tablets 500mg 30 count bottle (Drug) $653.89
- SKYRIZI (Biological) $563.61
- HUMIRA (Biological) $516.17
- STELARA (Biological) $477.08
- ENTYVIO (Biological) $461.44
- Entyvio (Biological) $423.33
- DUPIXENT (Biological) $338.33
- XIFAXAN (Drug) $318.54
- MAVYRET (Drug) $252.49
- Cook Medical Biliary (Device) $248.14
- CREON (Drug) $203.88
- LINZESS (Drug) $187.45
- Talicia (Drug) $138.20
- GENERAL BILIARY DEVICES (Device) $125.00
- Linzess (Drug) $123.88
- RESOLUTION CLIP (Device) $106.44
- SPYGLASS (Device) $104.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Cincinnati
Anita Afzali, Md, MD
Gastroenterology — Payments: $1.0M
Dr. Allan Peck, M.d, M.D
Gastroenterology — Payments: $481,678
Kara De Felice, M.d, M.D
Gastroenterology — Payments: $472,231
Dr. Ravi Ravinuthala, M.d, M.D
Gastroenterology — Payments: $401,840
Luis Lara, Md, MD
Gastroenterology — Payments: $174,958
Dr. Lisa Lestina, M.d, M.D
Gastroenterology — Payments: $163,406